ORTEXORTEX News
Tracking UNM? Get live short interest, options flow, and signals on ORTEX.Sign up free →
UN
Earnings PreviewUNM

UNM Shorts Hit a Fresh High, Now Up 24% in a Month

By ORTEX News · Edited by , Editor, ORTEX NewsUpdated 2 min readdata as of 31 Oct 2026, 04:02

Produced automatically from ORTEX data and published under the ORTEX News editorial standards set by Peter Hillerberg, Editor, ORTEX News. How we publish

ShareXLinkedInReddit

UNM short interest has climbed to 5.2 million shares, 3.1% of the free float, the highest level recorded in the data and a 24% increase over the past month, with the rate of accumulation accelerating sharply in the week before Monday's Q3 print.

The pace of that rebuild is the notable shift since the last note on October 24, which flagged 4.5 million shares short at 2.7% of float. The past week alone added another 15%, bringing the weekly move to more than two standard deviations above UNM's typical weekly short interest change over the past year. That acceleration happened without any tightening in the borrow market. Availability remains extremely loose, with over 109 million shares available to borrow against short interest of just over 5 million, and the cost to borrow has actually fallen 22% on the week to 0.37%. Shorts are not fighting for access to stock. They are adding positions deliberately, in a frictionless lending environment, ahead of a scheduled catalyst.

The stock itself has drifted in the opposite direction from its closest peers. UNM gained roughly 1% on the week, while CNO rose 7.5% and LNC gained 2.9%. That underperformance relative to insurance peers coincides with the short build, though the stock is still up 3.3% over the past month and closed at $91.14. The ORTEX short score has edged up to 35.8 from 33.3 ten days ago, a modest but consistent move higher. The put/call ratio, at 0.069, is slightly above its 20-day average but well within normal range, so options positioning is not signalling unusual defensiveness.

Analyst opinion is broadly constructive but divided on the degree of upside. Wells Fargo lifted its target modestly to $102 in mid-October while holding an Overweight rating. Barclays trimmed to $109 from $110 at the start of the month, also staying Overweight. Morgan Stanley, at Equal-Weight, has a target of $92, barely above the current price. The mean target across the coverage sits at around $102, implying roughly 12% upside from Friday's close. The bull case centres on UNM's group benefits franchise generating returns on equity above 20%, strong free cash flow conversion, and a favourable rate environment. The concern is on the liability side: group disability benefit ratios have been running higher than the Street would like, with projections for 2025 and 2026 above 62%, and long-term care incidence rates add a further uncertainty around the GAAP assumption review process. That is precisely the tension the Monday print is likely to resolve, or deepen.

Wikipedia attention for UNM is running at a z-score of 2.7 against its own 90-day history, the highest retail attention reading in the period tracked. That is a measure of attention, not a revenue signal, but it confirms that the upcoming report is drawing more eyes than usual to the stock.

The Q3 report on November 3 will land with short interest at a multi-year peak, a borrow market that poses no friction for further additions, and a specific question mark over disability claims ratios that the Street has been repricing for two consecutive quarters.

Stocks in this article

See the live data behind this article on ORTEX.

Open UNM on ORTEX →

How this article was generated

Generated
31 Oct 2026, 04:17
Data as of
31 Oct 2026, 04:02
Prompt version
v1.0
Data sources
Short interestCost to borrowUtilizationOptions flowEarningsInstitutional positioningORTEX Alpha signalsRecent ORTEX notesAlt DataPrevious Mi Articles

ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data and reviewed by the ORTEX team. Content is informational only and does not constitute investment advice.